Silence Therapeutics (SLN) Current Assets (2018 - 2026)
Silence Therapeutics (SLN) posted Current Assets of $102.9 million for Q1 2026, down 13.32% sequentially from $118.7 million in Q4 2025, and down 39.42% YoY from $169.8 million in Q1 2025.
Silence Therapeutics (SLN) Current Assets (2018 - 2026) Analysis & Trends
Silence Therapeutics has reported Current Assets for 9 years, with the latest figure at $102.9 million in Q1 2026.
- Quarterly Current Assets fell 39.42% year-over-year to $102.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102.9 million (down 39.42% YoY) and the FY2025 annual result came in at $118.7 million, down 36.67% from the prior year.
- Current Assets fell to $102.9 million in Q1 2026 per SLN's latest filing, from $118.7 million in the prior quarter.
- Over five years, Current Assets peaked at $187.4 million in Q4 2024 and troughed at $100.6 million in Q4 2023.
- A 5-year average of $134.4 million and a median of $126.1 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2026: Current Assets jumped 86.32% in 2024, then slumped 39.42% in 2026.
- Over 5 years, Current Assets stood at $113.4 million in 2022, then fell by 11.33% to $100.6 million in 2023, then surged by 86.32% to $187.4 million in 2024, then slumped by 36.67% to $118.7 million in 2025, then dropped by 13.32% to $102.9 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $102.9 million, $118.7 million, and $133.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | 94.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94.28 Mn |
| Mar 31, 2026 | 102.85 Mn |
| Dec 31, 2025 | 118.66 Mn |
| Sep 30, 2025 | 133.63 Mn |
| Jun 30, 2025 | 148.55 Mn |
| Mar 31, 2025 | 169.79 Mn |
| Dec 31, 2024 | 187.37 Mn |
| Dec 31, 2023 | 100.56 Mn |
| Dec 31, 2022 | 113.41 Mn |
| Dec 31, 2021 | 116.38 Mn |
| Dec 31, 2020 | 100.88 Mn |
| Dec 31, 2019 | 48.17 Mn |
| Dec 31, 2018 | 37.96 Mn |